Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001300729 | SCV001489878 | likely benign | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542913 | SCV003551035 | uncertain significance | Inborn genetic diseases | 2021-07-28 | criteria provided, single submitter | clinical testing | The c.1324C>T (p.R442C) alteration is located in exon 10 (coding exon 10) of the COL7A1 gene. This alteration results from a C to T substitution at nucleotide position 1324, causing the arginine (R) at amino acid position 442 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV001300729 | SCV005189504 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001278986 | SCV001466041 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-08-25 | no assertion criteria provided | clinical testing |